NR 565 FINAL EXAM 2 2026 COMPREHENSIVE
ASSESSMENT SCRIPT SOLVED QUESTIONS
ANSWERS UPDATED REVIEW SET
◉ 1st generation cephalosporins drugs.
Answer: Cephradine (Anspor)
Cefazolin (ancef)
Cefadroxil (Duricef)
Cephalexin (keflex)
◉ 2nd generation cephalosporins drugs.
Answer: Cefuroxime sodium (Zinacef)
Cefuroxime (Ceftin)
Cefaclor
Cefprozil
Cefotetan (Cefotetan)
Cefoxitin (Mefoxin)
◉ 3rd generation cephalosporins drugs.
Answer: Cefdinir (Omincef)
Cefpodoxime (Vantin)
,Cefotaxime (Celizox)
Ceftazidime Fortax)
Ceftriaxone (Rocephin)
Cedax
Cefixime (Suprax)
◉ 4th generation cephalosporins drugs.
Answer: Cefepime (Maxipime)
◉ 1st generation cephalosporins active against.
Answer: gram (+) cocci
◉ 2nd generation cephalosporins active against.
Answer: gram (+)
increased activity for H. influenzae
bateroides fragilis
◉ 3rd generation cephalosporins active against.
Answer: uncommon gram (-) organisms
◉ 4th generation cephalosporins active against.
Answer: primarily Gram (+) and but also Gram (-)
,◉ which cephalosporins are best against gram (+) organisms.
Answer: cefdinir & cefpodoxime
◉ ADR for cephalosporins.
Answer: serum sickness
seizure
coagulation abnormalities
◉ indications for cephalosporins.
Answer: exacerbation of chronic bronchitis
AOM (when amoxicillin fails)
Sinusitis
◉ Pharmacodynamics of cephalosporins.
Answer: inhibit synthesis of bacterial cell wall
◉ Fluoroquinolone older drugs.
Answer: cipofloxacin (cipro)
norfloxacin (noroxin)
ofloacin (flovin)
, ◉ Fluoroquinolones new drugs.
Answer: gemifloxacin (factive)
levofloxacin (levaquin)
moxifloxacin (avelox)
◉ fluoroquinolones active against.
Answer: Gram (-) organisms
◉ Pharmacodynamics of fluoroquinolines.
Answer: Interferes with DNA synthesis leading to inability to divide
and ultimately, cell death
◉ Fluoroquinolones indications.
Answer: PNA
sinusitis
UTI
proctitis
bronchitis
skin, joint infections
Travelers diarrhea (!st line therapy)
◉ black box warning for fluoroquinolones.
ASSESSMENT SCRIPT SOLVED QUESTIONS
ANSWERS UPDATED REVIEW SET
◉ 1st generation cephalosporins drugs.
Answer: Cephradine (Anspor)
Cefazolin (ancef)
Cefadroxil (Duricef)
Cephalexin (keflex)
◉ 2nd generation cephalosporins drugs.
Answer: Cefuroxime sodium (Zinacef)
Cefuroxime (Ceftin)
Cefaclor
Cefprozil
Cefotetan (Cefotetan)
Cefoxitin (Mefoxin)
◉ 3rd generation cephalosporins drugs.
Answer: Cefdinir (Omincef)
Cefpodoxime (Vantin)
,Cefotaxime (Celizox)
Ceftazidime Fortax)
Ceftriaxone (Rocephin)
Cedax
Cefixime (Suprax)
◉ 4th generation cephalosporins drugs.
Answer: Cefepime (Maxipime)
◉ 1st generation cephalosporins active against.
Answer: gram (+) cocci
◉ 2nd generation cephalosporins active against.
Answer: gram (+)
increased activity for H. influenzae
bateroides fragilis
◉ 3rd generation cephalosporins active against.
Answer: uncommon gram (-) organisms
◉ 4th generation cephalosporins active against.
Answer: primarily Gram (+) and but also Gram (-)
,◉ which cephalosporins are best against gram (+) organisms.
Answer: cefdinir & cefpodoxime
◉ ADR for cephalosporins.
Answer: serum sickness
seizure
coagulation abnormalities
◉ indications for cephalosporins.
Answer: exacerbation of chronic bronchitis
AOM (when amoxicillin fails)
Sinusitis
◉ Pharmacodynamics of cephalosporins.
Answer: inhibit synthesis of bacterial cell wall
◉ Fluoroquinolone older drugs.
Answer: cipofloxacin (cipro)
norfloxacin (noroxin)
ofloacin (flovin)
, ◉ Fluoroquinolones new drugs.
Answer: gemifloxacin (factive)
levofloxacin (levaquin)
moxifloxacin (avelox)
◉ fluoroquinolones active against.
Answer: Gram (-) organisms
◉ Pharmacodynamics of fluoroquinolines.
Answer: Interferes with DNA synthesis leading to inability to divide
and ultimately, cell death
◉ Fluoroquinolones indications.
Answer: PNA
sinusitis
UTI
proctitis
bronchitis
skin, joint infections
Travelers diarrhea (!st line therapy)
◉ black box warning for fluoroquinolones.